Could individuals from countries using BCG vaccination be resistant to SARS-CoV-2 induced infections?

Simple item page
buir.contributor.authorYazar, Volkan
buir.contributor.authorGürsel, İhsan
dc.citation.epage36en_US
dc.citation.issueNumber1en_US
dc.citation.spage29en_US
dc.citation.volumeNumber8en_US
dc.contributor.authorAyanoğlu, İ. C.
dc.contributor.authorİpekoğlu, E. M.
dc.contributor.authorYazar, Volkan
dc.contributor.authorYılmaz, İ. C.
dc.contributor.authorGürsel, İhsan
dc.contributor.authorGürsel, M.
dc.date.accessioned2021-03-04T11:48:49Z
dc.date.available2021-03-04T11:48:49Z
dc.date.issued2020
dc.departmentDepartment of Molecular Biology and Geneticsen_US
dc.description.abstractThe lower than expected number of SARS-CoV-2 cases in countries with fragile health systems is puzzling. Herein, we hypothesize that BCG vaccination policies and vaccine strain preferences adopted by different countries might influence the SARS-CoV-2 transmission patterns and/or COVID-19 associated morbidity and mortality. We also postulate that until a specific vaccine is developed, SARS-CoV-2 vulnerable populations could be immunized with BCG vaccines to attain heterologous nonspecific protection from the new coronavirus. In the lights of our investigations the most resistant countries appear to be the ones using Group I BCG strain. Within these countries, however, those who employs Russian strain is even more protected against COVID-19 infection.en_US
dc.description.provenanceSubmitted by Zeynep Aykut (zeynepay@bilkent.edu.tr) on 2021-03-04T11:48:49Z No. of bitstreams: 1 Could_individuals_from_countries_using_bcg_vaccination_be_resistant_to_sars_cov_2_induced_infections.pdf: 1332192 bytes, checksum: 373f6e380fb3510f3b425d5fe497bb2c (MD5)en
dc.description.provenanceMade available in DSpace on 2021-03-04T11:48:49Z (GMT). No. of bitstreams: 1 Could_individuals_from_countries_using_bcg_vaccination_be_resistant_to_sars_cov_2_induced_infections.pdf: 1332192 bytes, checksum: 373f6e380fb3510f3b425d5fe497bb2c (MD5) Previous issue date: 2020en
dc.identifier.doi10.25002/tji.2020.1250en_US
dc.identifier.issn1301-109X
dc.identifier.urihttp://hdl.handle.net/11693/75779
dc.language.isoTurkishen_US
dc.publisherTurkish Society of Immunologyen_US
dc.relation.isversionofhttps://dx.doi.org/10.25002/tji.2020.1250en_US
dc.source.titleTurkish Journal of Immunologyen_US
dc.subjectBCGen_US
dc.subjectCOVID-19en_US
dc.subjectSARS-CoV-2 infectionsen_US
dc.subjectProtectionen_US
dc.titleCould individuals from countries using BCG vaccination be resistant to SARS-CoV-2 induced infections?en_US
dc.title.alternativeVerem aşısı uygulayan ülkelerin bireyleri SARS-CoV-2 virüsünün yol açtığı enfeksiyona karşı daha dirençli olabilir mi?en_US
dc.typeReviewen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Could_individuals_from_countries_using_bcg_vaccination_be_resistant_to_sars_cov_2_induced_infections.pdf
Size:
1.27 MB
Format:
Adobe Portable Document Format
Description:
View / Download
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Scholarly Publications - Molecular Biology and Genetics